Skip to main content
XTPL S.A. logo

XTPL S.A. — Investor Relations & Filings

Ticker · XTP ISIN · PLXTPL000018 LEI · 259400H9PEQYON2NI017 WAR Manufacturing
Open in API
Filings indexed 1,313 across all filing types
Latest filing 2024-02-07 Regulatory Filings
Country PL Poland
Listing WAR XTP

About XTPL S.A.

https://xtpl.com/

XTPL S.A. is a deep-tech company that develops and commercializes a proprietary additive manufacturing technology for the ultra-precise printing of nanomaterials. Its core technology, Ultra-Precise Dispensing (UPD), enables the creation of conductive and non-conductive structures at the microscale, supporting the production of next-generation electronics. The company offers its solutions through industrial modules designed for integration into manufacturing lines and complete laboratory systems, such as the Delta Printing System, for prototyping and research. XTPL's technology is targeted at high-growth sectors including semiconductors, advanced packaging, displays, consumer electronics, HealthTech, and automotive, facilitating miniaturization and enhanced device functionality.

Recent filings

Filing Released Lang Actions
Uznanie ochrony patentowej przez Urząd Patentów i Znaków Towarowych Stanów Zjednoczonych. - Content (EN)
Regulatory Filings Classification · 99% confidence The document reports on a specific legal/intellectual property event: the receipt of a notice of allowance for a patent from the US Patent and Trademark Office. It discusses the legal basis (Article 17(1) MAR - confidential information) and the strategic implications of this patent. This content relates directly to significant legal matters or intellectual property developments that impact the company's value and operations. It is not a standard financial report (10-K, IR, ER), a management change (MANG), or a shareholder vote (DVA). While it is a regulatory disclosure under MAR, the most specific category that covers significant legal proceedings or material corporate events not covered by other specific financial/governance codes is often the 'Legal Proceedings Report' (LTR) or, if it's a general material disclosure not fitting elsewhere, 'Regulatory Filings' (RNS). Given the focus on a patent grant, which is a material legal/IP event, LTR is a strong candidate, but since it's a positive IP development rather than a lawsuit or regulatory action against the company, and it's a specific disclosure under MAR, the general 'Regulatory Filings' (RNS) serves as the best fit for miscellaneous material announcements that don't align perfectly with the other specific categories like DIV, CAP, or MANG. However, LTR is defined as 'Legal Proceedings Report' which usually implies litigation. Since this is a patent grant announcement, which is a material corporate event disclosure under MAR, and it doesn't fit the other specific categories well, RNS (Regulatory Filings/Miscellaneous) is the most appropriate fallback for a material, non-financial, non-governance specific announcement.
2024-02-07 English
Uznanie ochrony patentowej przez Urząd Patentów i Znaków Towarowych Stanów Zjednoczonych. - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement in Polish by the Management Board ("Zarząd") of XTPL S.A. It details the receipt of information regarding the approval of patent claims by the United States Patent and Trademark Office for a specific invention. The text discusses the implications for commercialization, strategy, and concludes that the event constitutes inside information under MAR (Market Abuse Regulation), requiring immediate disclosure. This type of announcement, concerning legal/intellectual property developments that are material to the company's value, fits best under the 'Legal Proceedings Report' (LTR) category, as it relates to the protection and status of intellectual property rights, which often involves regulatory/legal bodies like patent offices. It is not a standard financial report (10-K, IR, ER), a management change (MANG), or a general regulatory filing (RNS), but a specific update on a legal/IP asset.
2024-02-07 Polish
Uznanie ochrony patentowej od Urząd Patentów i Znaków Towarowych Stanów Zjednoczonych. - Content (EN)
Legal Proceedings Report Classification · 95% confidence The document is a formal report detailing a specific legal/intellectual property event: the receipt of a notice of allowance for a patent from the US Patent and Trademark Office. It discusses the legal basis (Article 17(1) MAR - confidential information) and the strategic implications of this patent grant. This content directly relates to significant legal matters and intellectual property protection, which aligns best with the 'Legal Proceedings Report' (LTR) category, as it is a report on a significant legal/regulatory outcome concerning the company's assets, even though it is a positive development rather than a lawsuit. It is not an earnings release (ER), a general regulatory filing (RNS), or a management change (MANG). Given the focus on patent allowance and legal protection, LTR is the most specific fit among the provided options.
2024-01-30 English
Uznanie ochrony patentowej od Urząd Patentów i Znaków Towarowych Stanów Zjednoczonych. - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement from the Management Board (Zarząd) of XTPL S.A. regarding the approval of patent claims by the United States Patent and Trademark Office for a specific invention. It details the date of approval, the history of the application, the company's current patent portfolio, and concludes that this information constitutes inside information under MAR regulations. This type of announcement, concerning legal/intellectual property developments that are material to the company's value and strategy, fits best under the 'Legal Proceedings Report' (LTR) category, as it relates to the protection of intellectual property rights, which often involves legal processes and outcomes. It is not a standard financial report (10-K, IR, ER), a management change (MANG), or a general regulatory filing (RNS). Given the specific nature of patent approval, LTR is the most precise fit among the provided options, although it is not strictly a 'lawsuit' report, it covers significant legal/IP milestones.
2024-01-30 Polish
Zawarcie niewyłącznej umowy dystrybucji rozwiązań technologicznych Emitenta na terenie Tajwanu i Chin. - Content (EN)
Regulatory Filings Classification · 95% confidence The document announces the signing of a non-exclusive distribution agreement between XTPL S.A. and Sigma Technology Corporation for technology solutions in Taiwan and China. It explicitly states the legal basis is 'Article 17 (1) MAR - confidential information,' which pertains to the disclosure of inside information under the Market Abuse Regulation (MAR). This type of announcement, detailing a significant business contract or strategic development that constitutes inside information, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or corporate governance filings (like DEF 14A, DVA). It is a general regulatory disclosure concerning a material business event. Since it is a specific regulatory announcement regarding a material contract, and 'Regulatory Filings' (RNS) is the fallback for miscellaneous regulatory disclosures that don't fit elsewhere, RNS is the most appropriate classification. It is not a merger/takeover (TAR), nor is it a director's dealing (DIRS) or a capital change (CAP).
2024-01-23 English
Zawarcie niewyłącznej umowy dystrybucji rozwiązań technologicznych Emitenta na terenie Tajwanu i Chin. - Content (PL)
Regulatory Filings Classification · 95% confidence The document text, written in Polish, announces the signing of a non-exclusive distribution agreement between the Issuer (XTPL S.A.) and Sigma Technology Corporation for the territories of Taiwan and China. The agreement concerns the promotion and sale of XTPL's technological solutions, particularly in the semiconductor, display, and optoelectronics sectors. The management explicitly states that this information qualifies as inside information under MAR Article 7(1) because its execution could significantly impact future revenue and investor perception. This type of announcement, detailing a significant commercial contract or partnership that affects future financial performance, most closely aligns with a general regulatory announcement or a specific corporate action announcement. Since there is no specific category for 'Distribution Agreement' or 'Commercial Contract,' and it is a formal disclosure of material information, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for significant, non-standard disclosures. Given the content is the substance of the agreement itself, not an announcement *about* a report, RNS is the most appropriate fit among the provided options.
2024-01-23 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.